Subscribe to our feed.

Symic secures $25 million in Series A-2 financing to advance clinical-stage biotherapeutics platform

December 1, 2015 — - Company Is Currently Investigating Its Lead Candidate, SB-030, in the Phase 1/2 SHIELD Clinical Trial - Read More

Startup licenses Purdue syringe design that could improve administration of concentrated dosages of insulin

November 30, 2015 — WEST LAFAYETTE, Ind., and INDIANAPOLIS - The founder of a medical device startup based on a Purdue University innovation says his company could help people in the advanced stages of diabetes, which affects more than 9 percent of the population in the United States, according to the Centers for Disease Control and Prevention. Read More